Jenni Majumdar: What Changing Blood Transfusion Guidelines Mean for Patients and Surgical Teams
Jenni Majumdar, Assistant Professor at Hunter College, shared a post on LinkedIn:
“For more than 80 years, Jehovah’s Witnesses have been instructed to refuse blood transfusions.
In September, that changed in a major way.
Members can now individually decide whether to accept donated red blood cells, plasma, and platelets.
The prohibition on transfusions of whole blood remains.
This is a significant development for patients and the surgical teams caring for them, particularly when an operation carries a risk of major bleeding.
As a nurse anesthetist, I find this especially interesting because of how much our approach to blood transfusions has evolved.
For decades, researchers have been trying to answer a surprisingly complicated question. When does giving someone blood actually improve their outcome?
We’ve learned that many stable patients do just as well with fewer transfusions.
But newer research suggests that patients experiencing a heart attack may benefit from receiving blood sooner.
And when someone is bleeding rapidly during surgery, waiting for a particular hemoglobin number can be dangerous.
There are also some fascinating things about how we manage blood loss that most people don’t realize.
- Your oxygen monitor can read 100% even when you’re dangerously anemic.
- We can sometimes collect blood lost during surgery, process it, and give the patient’s own red blood cells back.
- Two patients with exactly the same hemoglobin level may need completely different treatments.
For this week’s Art of Anesthesia, I wanted to explore the Jehovah’s Witness announcement, the history of operating without donor blood, and the research that continues to shape when and how we transfuse patients.
I also get into what happens when someone loses blood during surgery, why IV fluids can’t replace everything blood does, and how anesthesia teams make these decisions.
There is so much interesting science behind something most people probably haven’t thought much about, and I love getting to explain it.
Read the full article.”

Stay updated with Hemostasis Today.
-
Nov 21, 2026, 08:17Doaa El Demerdash: The Bridge Meeting Fosters International Dialogue on Hemophilia Care
-
Nov 21, 2026, 08:16Emily Branchard: Uncoupling Anticancer and Antiplatelet Effects of Dipyridamole Analogs
-
Nov 21, 2026, 08:10Rory R Koenen: Xin Xin Earns PhD for Research on Extracellular Vesicles and Vascular Inflammation
-
Nov 21, 2026, 08:06Andrew Hill: How Do You Build Loyalty when Financial Incentives Are off the Table?
-
Nov 21, 2026, 08:00Kevin Dean: How Leptin Receptor Positive Stromal Cells Regulate Platelet Production
-
Nov 21, 2026, 07:59William Aird: The Blood Project Makes Its First Appearance at ASH 2026
-
Nov 21, 2026, 07:52Michael Holmes: Why Matched Platelet Donations Matter for Refractory Patients
-
Nov 21, 2026, 07:18Raising Awareness of Inherited Bleeding Disorders in Women and Girls – World Federation of Hemophilia
-
Nov 21, 2026, 07:10Emmanuel J Favaloro: Latest Publication Posted Online at Seminars in Thrombosis and Hemostasis